From August 5 to 6, 2020, Asia Pharmaceutical Industry Conference 2020 was held in Shanghai. GLO was invited to give a keynote speech. Partner, Alan (Lei) Zhou, shared the theme of "Legal Issues in Clinical Trials of Innovative Drugs". The event brought together experts, executives and decision makers from major multinational pharmaceutical enterprises, domestic pharmaceutical leading enterprises, biotechnology companies, scientific research institutes, pharmaceutical manufacturers of raw materials and excipients, contract outsourcing enterprises such as CMO / cdmo, pharmaceutical manufacturing equipment and pharmaceutical packaging enterprises and other experts, executives and decision makers.

Alan elaborated on the three main modules of drug clinical trial legal subject overview, common legal risks and risk prevention and control suggestions. Through policy, data and cases, Alan expounded the legal issues in drug clinical trials, such as test data compliance, subject compensation, human genetic resource management, intellectual property protection, anti commercial bribery and other legal issues through different aspects of policies, data and cases. He analyzed and interpreted the trend of policies and regulations in the field of life science and medical treatment in a professional way, and discussed with the participants by answering relevant legal questions. Participants said that they benefited a lot.

We have extensive experience in Life Sciences & Healthcare (L&H) practice, which allows us to take into account both the business and legal needs for our clients. We leverage the perfect combination of characteristics of L&H sector and our professional expertise to provide efficient and feasible solutions to our clients. We always adhering to the philosophy and principles that emphasizing both industry background and legal knowledge, legal compliance and commercial feasibility.
 
Click below button to download PPT.